BIO-TECHNE Corp vs VNET Group Inc — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: BIO-TECHNE Corp is far larger — about 5.1× VNET Group Inc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals.
| TECH | VNET | |
|---|---|---|
Market Cap | $11.16B | $2.19B |
Sector | Health | Technology |
52-Week High | $72.12 | $14.03 |
52-Week Low | $43.31 | $7.34 |
Enterprise Value | $11.24B | $5.32B |
Dividend Yield | 0.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →